PHAR

$0.00

(

0.00%

)
Quote details

stock

Pharming Group NV

NASDAQ | PHAR

14.52

USD

$0.00

(

0.00%

)

At Close (As of Sep 8, 2025)

$1.05B

Market Cap

-

P/E Ratio

-0.14

EPS

$17.07

52 Week High

$6.96

52 Week Low

HEALTHCARE

Sector

PHAR Chart

Recent Chart
Price Action

PHAR Technicals

Tags:

PHAR Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $262M
Total Revenue $297M
Cost Of Revenue $35M
Costof Goods And Services Sold $35M
Operating Income -$8.6M
Selling General And Administrative $92M
Research And Development $83M
Operating Expenses $270M
Investment Income Net -
Net Interest Income -$5.1M
Interest Income $4.9M
Interest Expense $8.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16M
Income Before Tax -$8.2M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit $245K
Ebitda $16M
Net Income -$11M

Revenue & Profitability

Earnings Performance

PHAR Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $400M
Total Current Assets $278M
Cash And Cash Equivalents At Carrying Value $55M
Cash And Short Term Investments $55M
Inventory $56M
Current Net Receivables $50M
Total Non Current Assets $122M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $61M
Intangible Assets Excluding Goodwill $61M
Goodwill -
Investments -
Long Term Investments $4.2M
Short Term Investments $113M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $179M
Total Current Liabilities $74M
Current Accounts Payable $10M
Deferred Revenue -
Current Debt -
Short Term Debt $6.9M
Total Non Current Liabilities $105M
Capital Lease Obligations $30M
Long Term Debt $78M
Current Long Term Debt $4.2M
Long Term Debt Noncurrent -
Short Long Term Debt Total $108M
Other Current Liabilities $48M
Other Non Current Liabilities -
Total Shareholder Equity $221M
Treasury Stock -
Retained Earnings -$275M
Common Stock $7.8M
Common Stock Shares Outstanding $69M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$1.8M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $16M
Capital Expenditures $796K
Change In Receivables -
Change In Inventory -$503K
Profit Loss -
Cashflow From Investment $32M
Cashflow From Financing -$34M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout $0
Dividend Payout Common Stock $0
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$8.5M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $262M
Total Revenue $297M
Cost Of Revenue $35M
Costof Goods And Services Sold $35M
Operating Income -$8.6M
Selling General And Administrative $92M
Research And Development $83M
Operating Expenses $270M
Investment Income Net -
Net Interest Income -$5.1M
Interest Income $4.9M
Interest Expense $8.7M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $16M
Income Before Tax -$8.2M
Income Tax Expense $2.4M
Interest And Debt Expense -
Net Income From Continuing Operations -$12M
Comprehensive Income Net Of Tax -
Ebit $245K
Ebitda $16M
Net Income -$11M

PHAR News

PHAR Profile

Pharming Group NV Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Pharming Group NV, a specialty pharmaceutical company, develops products for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company is headquartered in Leiden, the Netherlands.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-0.80%
$18.47
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
YAAS
-21.16%
$0.08
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
RIG
+2.93%
$3.16
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.53%
$16.79
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
QBTS
+0.32%
$15.42
CRWV
+5.00%
$93.55
MULN
-17.38%
$0.14
ITUB
-0.70%
$7.05
NGD
+3.49%
$6.52
JD
+4.45%
$32.85
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-0.80%
$18.47
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
YAAS
-21.16%
$0.08
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
MGIH
+42.13%
$2.25
T
-2.33%
$28.90
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
GOOGL
-0.31%
$234.04
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
WULF
+0.76%
$9.19
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
RIG
+2.93%
$3.16
NOK
+0.76%
$4.58
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.53%
$16.79
RGTI
+0.33%
$15.15
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
QBTS
+0.32%
$15.42
CRWV
+5.00%
$93.55
MULN
-17.38%
$0.14
ITUB
-0.70%
$7.05
NGD
+3.49%
$6.52
JD
+4.45%
$32.85

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.